#LegacyContent: Assessing the risk stratification of breast cancer polygenic risk scores in a Brazilian cohort. Authors from @brynmawrcollege.bsky.social Free in the #OpenArchive: https://www.jmdjournal.org/article/S1525-1578(24)00150-8/fulltext

A new case report in CAP Today reminds us that “it is imperative to consider that a negative molecular testing result does not equate with absence of variation.” Learn how this type of discrepancy is possible in testing a tumor in our latest case report: www.amp.org/clinical...

It's official: FDA rescinds final rule regulating laboratory-developed testing procedures as medical devices. www.medtechdive.com/news/FDA-res...

🥳 Before National Postdoc Appreciation Week ends, we want to remind all postdocs interested in joining AMP that associate membership for postdocs is free for the duration of your training (up to 7 years): www.amp.org/membersh... #NPAW2025 #NPAW #postdocs

Development of a Multiplex Real-Time PCR Assay for the Rapid Detection of the Asian-Type DEL. #OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(25)00161-8/fulltext

Thank you to all our peer reviewers! Interested in being a reviewer for JMD? Create your account online and add your expertise so our editors can find you when searching for topically appropriate experts. www.editorialmanager.com/jmdi/default...

🧬At #AMPath2025, plenary speaker Robin Coope, Ph.D., of The University of British Columbia will explore challenges and opportunities in automating sample preparation for sequencing tumors. Don't miss this timely discussion! Register: amp25.amp.org/progra...#AMPath2025,

During this #PeerReviewWeek, and every other week, AMP and @jmdiagn.bsky.social are grateful for all the peer reviewers who help maintain integrity, ensure accuracy and spur innovation in research and scientific publishing! #PRW2025

🧬cfDNA from CSF is rapidly emerging as a rich source for tumor characterization via liquid biopsies. Join us Oct. 9 for a FREE webinar examining factors that influence cfDNA detection and the utilization of tumor biomarkers from CSF cfDNA. Register: educate.amp.org/loca...

Age-Stratified Epidemiology of Respiratory Pathogens and the Value of Customizable Syndromic Testing Using the LIAISON PLEX Respiratory Flex Assay. From @ampath.bsky.social member Kaisha Gonzalez at #Diasorin Full text: https://loom.ly/i02MbNQ

#ArticleinPress: Analytical and Clinical Evaluation of the AltoStar Adenovirus PCR Kit 1.5 and the AltoStar Automation System AM16 For Adenovirus Detection in Plasma and Stool Samples Full text: https://www.jmdjournal.org/article/S1525-1578(25)00199-0/fulltext

Cell-Free DNA, Tumor Molecular Concordance, and Clinical Correlates of Patients with Cancer Treated in a Large Community Health Care Network. Authors from @cmu.edu. #OpenAccess text: https://loom.ly/DljlxKQ

#ArticleinPress: Solving the :: Fusion Nomenclature Challenge for File and Directory Naming #OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(25)00198-9/fulltext

#LegacyContent: Mono- and biallelic replication-coupled gene editing discriminates dominant-negative and loss-of-function variants of DNA mismatch repair genes. #OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(24)00131-4/fulltext

Development of an End-to-End Total RNA Sequencing Quality Control Framework for Blood-Based Biomarker Discovery Full text: https://www.jmdjournal.org/article/S1525-1578(25)00143-6/fulltext

#LegacyContent: Plasma protein profiling to discern indolent from advanced systemic mastocytosis. Authors from @ki.se and @uu.se #OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(24)00130-2/fulltext

There’s still time to register for GetAMPed! at #AMPath25. Join us for a hands-on course to get you up to speed in technologies used in molecular pathology. Register now: amp25.amp.org/progra...

#LegacyContent: Analytical Validation of the Multitarget Stool RNA Test for Colorectal Cancer Screening. Authors from @washumedicine.bsky.social Full #OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(24)00100-4/fulltext

#ArticleinPress: Two-dimensional polymerase chain reaction for identifying the HLA alleles associated with adverse drug reactions. Full text: https://www.jmdjournal.org/article/S1525-1578(25)00196-5/fulltext

Validation of Human Papillomavirus Genotyping by Oxford Nanopore Sequencing in Formalin-Fixed, Paraffin-Embedded Tissues and ThinPrep Anal and Gynecologic Samples. Full text: https://www.jmdjournal.org/article/S1525-1578(25)00133-3/fulltext

#ArticleinPress: Evaluation of Genomic Proximity Mapping (GPM) for Detecting Genomic and Chromosomal Structural Variants in Constitutional Disorders. @seattlechildrens.org Full text: https://www.jmdjournal.org/article/S1525-1578(25)00194-1/fulltext

#ArticleinPress: Evaluation of Atypical FISH Findings by RNA Sequencing. From @ampath.bsky.social member K. Geiersbach and colleagues from @mayoclinic.org https://www.jmdjournal.org/article/S1525-1578(25)00197-7/fulltext

📣Today’s the day! Case study submissions are due by 11:59 p.m. ET Submit yours so you can be ready to join us in Boston for #AMPath25 amp25.amp.org/abstra...#AMPath25

Have you completed your case study submission for #AMPath25? Submissions are due TOMORROW, so make sure you’ve completed yours before the deadline! amp25.amp.org/abstra...#AMPath25?

Morphological Bone Score as a Predictive Tool for Molecular Profiling Success. #OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(25)00137-0/fulltext

#ArticleinPress: High-Specificity Detection of Ultraviolet Mutational Signatures in Circulating Tumor DNA for Diagnostic Classification of Cutaneous and Unknown Primary Tumors using FoundationOne Liquid CDx. #OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(25)00193-X/fulltext

📣TODAY at 1 p.m. Eastern: Join our latest AMP Horizons webinar to explore how AI is transforming infectious disease diagnostics by improving accuracy, streamlining lab workflows and optimizing data use to enhance patient outcomes. 🔗Register here: educate.amp.org/loca...

Don’t miss today’s FASEB Advocacy Town Hall meeting at 12 pm ET! Hear from John Martens of Federal Science Partners on what’s ahead for research funding in FY26 and Congress’s anticipated fall agenda. Register now: buff.ly/cq3AnId

#ArticleinPress: From expert knowledge to validation resources – a case for using in silico approaches to close the gap in available reference materials for common germline genetic tests. Full text: https://www.jmdjournal.org/article/S1525-1578(25)00195-3/fulltext

#LegacyContent: Economic Impact of Whole Genome Sequencing and Whole Transcriptome Sequencing Versus Routine Diagnostic Molecular Testing to Stratify Patients with B-Cell Acute Lymphoblastic Leukemia. #OpenArchive: https://www.jmdjournal.org/article/S1525-1578(24)00102-8/fulltext

Learn how AI can be used in clinical microbiology to: ✅Enhance diagnostic accuracy ✅Automate laboratory workflows ✅Improve patient outcomes Attend the next AMP Horizons webinar on Sept. 3 at 1 p.m. Eastern (CME/CMLE credit available!) Register: educate.amp.org/loca...

🔬 Many patients don’t fully understand molecular pathology’s role in their care. This video can help patients and advocates connect the dots between lab work and their care paths. ▶️ Watch and share: vimeo.com/899576754 #MolecularPathology #LabMedicine #PatientSupport

Attend the next AMP Horizons webinar on Sept. 3 at 1 p.m. Eastern to learn how harnessing #AI technologies can enhance infectious disease diagnostics and ultimately improve patient outcomes. Register 👉🏽educate.amp.org/loca...#AI

Join FASEB’s Advocacy Town Hall Meetings. Held on the first and third Tuesday each month from 12 to 1 p.m. ET, these virtual meetings are open to all. Get updates from Capitol Hill and contribute to community discussions. Next meeting: 9/2. Register: hubs.ly/Q03z6Y040

🥳 Congratulations to our 3rd #AMPtutorials social media challenge winner Ting Zhao for her post on TMPRSS2::ERG fusion in prostate cancer! x.com/TingZhaoPath... She’s won free registration to #AMPath25. The challenge reopens in November for chances to win registration for AMP 2026!

Guest Editorial: Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Consensus Conference: Report from the Laboratory Challenges Working Group https://www.jmdjournal.org/article/S1525-1578(25)00115-1/fulltext

A Comparative Study of Medium-Coverage Genome Sequencing and SNP Array Technology in Identifying Chromosomal Abnormalities to Advance Prenatal and Postnatal Diagnosis. #OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(25)00119-9/fulltext

🐦Early bird gets the worm! (Or in this case, the discount.) Register for #AMPath2025 now to save on your registration fee. The discount ends Sept. 10, so make sure to sign up now to save! amp25.amp.org/regist...#AMPath2025

📣Kick off your #AMPath2025 experience with an interactive, in-depth course: Attend GetAMPed! on Nov. 12 to strengthen your foundational knowledge before the annual meeting. Sign up before Sept. 10 to get a discounted rate: amp25.amp.org/progra...

Now free & on demand: "Who Says You Can't Have It All: Rapid Comprehensive Molecular Profiling of Hematological Malignancies" featuring Sean Glenn, Ph.D., of Roswell Park Comprehensive Cancer Center, co-developer of the SureSelect Cancer Pan Heme Assay. www.amp.org/educatio...

This week AMP members & staffers attended #NGDx to discuss diagnostic advancements & technology innovation in healthcare. It provided great insight! Pictured: Genetic Discrimination: Impact of Genetic Test Results on Access to Life, Long-Term Care and Disability Insurance panel

AMP Horizons webinar (Sept. 3 at 1 p.m. Eastern): Find out how #AI can help improve diagnostic accuracy for infectious diseases, streamline laboratory workflows and enable more effective use of laboratory data to improve patient outcomes: educate.amp.org/loca...#AI

#LegacyContent Open-source bioinformatic pipeline to improve PMS2 genetic testing using short-read NGS data. Authors from @isciiisalud.bsky.social #OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(24)00118-1/fulltext

Missed the first-ever @ampath.bsky.social Middle East meeting? You're in luck! 9+ hours of its expert-led sessions are available on demand, ready to watch on your schedule. 💻 Purchase the bundle now: educate.amp.org/loca...

📣TODAY: Join our free webinar at 3 p.m. Eastern to learn new strategies for teaching and communicating with pathology trainees from a range of backgrounds (and with different learning preferences). #ScienceEducation #MolecularPathology 🔗us06web.zoom.us/meet...

Smart non-uniformity: Calibration of sequencing depth of a targeted gene panel to simultaneously detect somatic and germline variants. Authors from @monashuniversity.bsky.social. Full text: https://www.jmdjournal.org/article/S1525-1578(25)00117-5/fulltext

Performance Evaluation of a Commercial Automated Library Preparation System for Clinical Microbial Whole-Genome Sequencing Assays. @dgsomucla.bsky.social #OpenAccess text: https://www.jmdjournal.org/article/S1525-1578(24)00119-3/fulltext#OpenAccess

📣Register for #AMPath2025 now and save! Don’t wait until the last second to secure your AMP 2025 Meeting and Expo registration—secure your spot by Sept. 10 to get the early bird discount. amp25.amp.org/regist...

Looking for an interactive way to strengthen your molecular pathology knowledge before #AMPath2025? Attend GetAMPed! On Nov. 12 (the day before the meeting officially kicks off). CME and CMLE credits are available! Register: amp25.amp.org/progra...

🧬Screenings vs. diagnostic tests—what’s the difference This patient video breaks down the difference in clear terms. Share with patients, advocates and care teams. vimeo.com/956651246?... #MolecularTesting #PatientSupport #Pathology